Hers Menopause

Starting Hers’ menopause program means completing an online intake about symptoms, medical history, and health goals — no in-person visit required. A licensed provider trained in women’s health reviews the intake and determines eligibility; if appropriate, they prescribe a personalized combination that can include an estradiol pill or patch, a progesterone pill, and/or an estradiol vaginal cream. Approved medication ships directly to the customer, and ongoing care includes unlimited provider messaging for check-ins, side-effect questions, and dosage adjustments. Hers doesn’t publish an at-home lab-testing step as part of this specific program on its menopause page, so it isn’t clear from public information whether bloodwork is involved before a prescription is written.

Hers cites separate randomized, placebo-controlled clinical trials of oral estradiol and estradiol patches that each found a significant reduction in hot flashes as early as week 4. Progesterone is included for menopausal women with a uterus who are on estrogen therapy, to help protect the uterine lining, and a meta-analysis of randomized trials found oral micronized progesterone improved sleep quality compared to placebo. Separately, randomized trials cited by Hers found estradiol vaginal cream significantly improved vaginal dryness, itching, irritation, and thinning of the vaginal lining. It’s worth noting that hormone therapy is not FDA-approved for skin, sleep, heart, diabetes, or bone-loss benefits unrelated to menopause, or as a stand-alone treatment for postmenopausal bone loss ahead of non-estrogen options — so those benefits shouldn’t be assumed beyond the approved use case.

Treatment is organized as a single kit with up to three components (estradiol, progesterone, and vaginal cream) rather than requiring customers to piece together separate prescriptions, and the program includes educational resources on hormonal health alongside the medication itself.

The intake focuses on symptoms and eligibility rather than requiring customers to know which hormone product they need going in — the provider determines the combination. Hers doesn’t show pricing until after the intake is complete, which makes the process feel more like a guided consultation than a typical checkout, for better or worse depending on what a customer is looking for.

Customers get unlimited access to provider messaging for check-ins, questions, and dosage adjustments as part of ongoing care. Hers doesn’t publish specifics on longer-term monitoring (like scheduled follow-up labs) for the menopause program on its public pages.

Menopause treatment requires an online consultation, and a licensed provider trained in women’s health determines eligibility and the appropriate hormone combination before anything is prescribed. Hers is explicit that hormone therapy is not FDA-approved for perimenopause — it may be prescribed off-label for perimenopausal symptoms at a provider’s discretion — and is also not FDA-approved for skin, sleep, heart, diabetes, or unrelated bone-loss benefits, or as a sole treatment for postmenopausal bone loss ahead of non-estrogen options. Not available in all states.